scispace - formally typeset
C

Carl-Gerhard Gottfries

Researcher at University of Gothenburg

Publications -  118
Citations -  5384

Carl-Gerhard Gottfries is an academic researcher from University of Gothenburg. The author has contributed to research in topics: Dementia & Chronic fatigue syndrome. The author has an hindex of 40, co-authored 118 publications receiving 5165 citations. Previous affiliations of Carl-Gerhard Gottfries include Umeå University & Sahlgrenska University Hospital.

Papers
More filters
Journal ArticleDOI

The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders. A Nordic multicentre study.

TL;DR: None of the changes observed during the double-blind withdrawal period were identified as withdrawal symptoms or rebound phenomena and citalopram provoked few and comparatively mild side-effects.
Journal ArticleDOI

Membrane Lipids, Selectively Diminished in Alzheimer Brains, Suggest Synapse Loss as a Primary Event in Early‐Onset Form (Type I) and Demyelination in Late‐Onset Form (Type II)

TL;DR: The characteristic membrane lipid disturbance in AD type II was a loss of myelin lipids, the first time a fundamental biochemical difference has been shown between the two major forms of AD.
Journal ArticleDOI

Biochemical changes in dementia disorders of Alzheimer type (AD/SDAT).

TL;DR: In postmortem investigations of patients with dementia of Alzheimer type (AD/SDAT) the brain weight was significantly reduced when compared to controls and the activity of monoamine oxidase B was increased suggesting a proliferation of extra neuronal tissue in the AD/ SDAT-brains.
Journal ArticleDOI

A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia.

TL;DR: Results of ratings on the Gottfries‐Bråne‐Steen dementia rating scale indicated that both cognitive and emotional functioning improved significantly more in the citalopram‐ treated subgroup of patients with dementia than in the placebo‐treated subgroup.
Journal ArticleDOI

Determination of monoamine and monoamine metabolites in the human brain: post mortem studies in a group of suicides and in a control group.

TL;DR: Different nuclei and regions of the brain from patients who had committed suicide and from controls were analysed for their content of monoamine and monoamine metabolites.